A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis.
Tuberculosis is a serious global health problem caused by the bacterium Mycobacterium tuberculosis. There is an urgent need for discovery and development of new treatments, but this can only be accomplished through rapid and reproducible M. tuberculosis assays designed to identify potent inhibitors....
Main Authors: | Juliane Ollinger, Mai Ann Bailey, Garrett C Moraski, Allen Casey, Stephanie Florio, Torey Alling, Marvin J Miller, Tanya Parish |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3617142?pdf=render |
Similar Items
-
A high-throughput whole cell screen to identify inhibitors of Mycobacterium tuberculosis.
by: Juliane Ollinger, et al.
Published: (2019-01-01) -
Synthesis and anti-tubercular activity of 3-substituted benzo[b]thiophene-1,1-dioxides
by: N. Susantha Chandrasekera, et al.
Published: (2014-10-01) -
Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis
by: Sheo B. Singh, et al.
Published: (2018-06-01) -
In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis
by: Joshua Odingo, et al.
Published: (2017-09-01) -
Phenoxyalkylimidazoles with an oxadiazole moiety are subject to efflux in Mycobacterium tuberculosis.
by: Mai B Thayer, et al.
Published: (2021-01-01)